Table of Contents Author Guidelines Submit a Manuscript
Schizophrenia Research and Treatment
Volume 2013, Article ID 543842, 10 pages
http://dx.doi.org/10.1155/2013/543842
Clinical Study

The Neural Correlates of Mental Rotation Abilities in Cannabis-Abusing Patients with Schizophrenia: An fMRI Study

1Centre de Recherche de l’Institut Universitaire de Santé Mentale de Montréal, 7331 Hochelaga, Montreal, QC, Canada H1N 3V2
2Department of Psychiatry, Faculty of Medicine, University of Montreal, 2900 Edouard-Montpetit, Montreal, QC, Canada H3C 3J7
3Department of Psychiatry, Faculty of Medicine, University of Sherbrooke, 580 Bowen Sud, Sherbrooke, QC, Canada J1G 2E8
4Centre Hospitalier de l’Université de Montréal, 1058 St-Denis, Montreal, QC, Canada H2X 3J4
5Department of Physiology, Faculty of Medicine, University of Sherbrooke, 3001 12e Avenue Nord, Sherbrooke, QC, Canada J1H 5N4
6Department of Psychology, Bishop’s University, 2600 College, Sherbrooke, QC, Canada J1M 1Z7

Received 19 April 2013; Revised 20 June 2013; Accepted 2 July 2013

Academic Editor: Robin Emsley

Copyright © 2013 Stéphane Potvin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Kalkstein, I. Hurford, and R. C. Gur, “Neurocognition in schizophrenia,” Current Topics in Behavioral Neurosciences, vol. 4, pp. 373–390, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. K. H. Nuechterlein, D. M. Barch, J. M. Gold, T. E. Goldberg, M. F. Green, and R. K. Heaton, “Identification of separable cognitive factors in schizophrenia,” Schizophrenia Research, vol. 72, no. 1, pp. 29–39, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Stip, “Cognition, schizophrenia and the effect of antipsychotics,” Encephale, vol. 32, no. 3, part 1, pp. 341–350, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. M. F. Green, “What are the functional consequences of neurocognitive deficits in schizophrenia?” American Journal of Psychiatry, vol. 153, no. 3, pp. 321–330, 1996. View at Google Scholar · View at Scopus
  5. D. A. Regier, M. E. Farmer, D. S. Rae et al., “Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) study,” Journal of the American Medical Association, vol. 264, no. 19, pp. 2511–2518, 1990. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Cantor-Graae, L. G. Nordström, and T. F. McNeil, “Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden,” Schizophrenia Research, vol. 48, no. 1, pp. 69–82, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Koskinen, J. Löhönen, H. Koponen, M. Isohanni, and J. Miettunen, “Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis,” Schizophrenia Bulletin, vol. 36, no. 6, pp. 1115–1130, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. D. C. D'Souza, E. Perry, L. MacDougall et al., “The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis,” Neuropsychopharmacology, vol. 29, no. 8, pp. 1558–1572, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. T. H. Moore, S. Zammit, A. Lingford-Hughes et al., “Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review,” The Lancet, vol. 370, no. 9584, pp. 319–328, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Dervaux, X. Laqueille, M.-C. Bourdel et al., “Cannabis and schizophrenia: demographic and clinical correlates,” Encephale, vol. 29, no. 1, pp. 11–17, 2003. View at Google Scholar · View at Scopus
  11. S. Zammit, T. H. M. Moore, A. Lingford-Hughes et al., “Effects of cannabis use on outcomes of psychotic disorders: systematic review,” British Journal of Psychiatry, vol. 193, no. 5, pp. 357–363, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. D. J. Foti, R. Kotov, L. T. Guey, and E. J. Bromet, “Cannabis use and the course of schizophrenia: 10-year follow-up after first hospitalization,” American Journal of Psychiatry, vol. 167, no. 8, pp. 987–993, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. N. A. Crane, R. M. Schuster, P. Fusar-Poli, and R. Gonzalez, “Effects of cannabis on neurocognitive functioning: recent advances, neurodevelopmental influences, and sex differences,” Neuropsychology Review, vol. 23, no. 2, pp. 117–137, 2013. View at Publisher · View at Google Scholar
  14. R. D. Crean, N. A. Crane, and B. J. Mason, “An evidence-based review of acute and long-term effects of cannabis use on executive cognitive functions,” Journal of Addiction Medicine, vol. 5, no. 1, pp. 1–8, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Ranganathan and D. C. D'Souza, “The acute effects of cannabinoids on memory in humans: a review,” Psychopharmacology, vol. 188, no. 4, pp. 425–444, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. I. Grant, R. Gonzalez, C. L. Carey, L. Natarajan, and T. Wolfson, “Non-acute (residual) neurocognitive effects of cannabis use: a meta-analytic study,” Journal of the International Neuropsychological Society, vol. 9, no. 5, pp. 679–689, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. H. G. Pope Jr., A. J. Gruber, and D. Yurgelun-Todd, “Residual neuropsychologic effects of cannabis,” Current Psychiatry Reports, vol. 3, no. 6, pp. 507–512, 2001. View at Google Scholar · View at Scopus
  18. C. M. Coulston, M. Perdices, and C. C. Tennant, “The neuropsychological correlates of cannabis use in schizophrenia: lifetime abuse/dependence, frequency of use, and recency of use,” Schizophrenia Research, vol. 96, no. 1–3, pp. 169–184, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. P. DeRosse, A. Kaplan, K. E. Burdick, T. Lencz, and A. K. Malhotra, “Cannabis use disorders in schizophrenia: effects on cognition and symptoms,” Schizophrenia Research, vol. 120, no. 1–3, pp. 95–100, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. E. M. Loberg and K. Hugdahl, “Cannabis use and cognition in schizophrenia,” Frontiers in Human Neuroscience, vol. 3, p. 53, 2009. View at Google Scholar
  21. S. Potvin, C. Briand, A. Prouteau et al., “CANTAB explicit memory is less impaired in addicted schizophrenia patients,” Brain and Cognition, vol. 59, no. 1, pp. 38–42, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Schnell, D. Koethe, J. Daumann, and E. Gouzoulis-Mayfrank, “The role of cannabis in cognitive functioning of patients with schizophrenia,” Psychopharmacology, vol. 205, no. 1, pp. 45–52, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. R. A. Rabin, K. K. Zakzanis, and T. P. George, “The effects of cannabis use on neurocognition in schizophrenia: a meta-analysis,” Schizophrenia Research, vol. 128, no. 1–3, pp. 111–116, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Yücel, E. Bora, D. I. Lubman et al., “The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample,” Schizophrenia Bulletin, vol. 38, no. 2, pp. 316–330, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Potvin, C. C. Joyal, J. Pelletier, and E. Stip, “Contradictory cognitive capacities among substance-abusing patients with schizophrenia: a meta-analysis,” Schizophrenia Research, vol. 100, no. 1–3, pp. 242–251, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Myles, H. Newall, O. Nielssen, and M. Large, “The association between cannabis use and earlier age at onset of schizophrenia and other psychoses: meta-analysis of possible confounding factors,” Current Pharmaceutical Design, vol. 18, no. 32, pp. 5055–5069, 2012. View at Google Scholar
  27. E. M. Løberg, M. Nygård, J. Ø. Berle et al., “An fMRI study of neuronal activation in schizophrenia patients with and without previous cannabis use,” Front Psychiatry, vol. 3, p. 94, 2012. View at Publisher · View at Google Scholar
  28. S. Potvin, A. A. Sepehry, and E. Stip, “Meta-analysis of depressive symptoms in dual-diagnosis schizophrenia,” Australian and New Zealand Journal of Psychiatry, vol. 41, no. 10, pp. 792–799, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. F. Guillem, A. Mendrek, M. E. Lavoie, T. Pampoulova, and E. Stip, “Sex differences in memory processing in schizophrenia: an event-related potential (ERP) study,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 33, no. 1, pp. 1–10, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Lecardeur, A. Mendrek, and E. Stip, “Sexual dimorphism of spatial working memory profiles in schizophrenia,” Cognitive Neuropsychiatry, vol. 15, no. 4, pp. 397–405, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. F. de Vignemont, T. Zalla, A. Posada et al., “Mental rotation in schizophrenia,” Consciousness and Cognition, vol. 15, no. 2, pp. 295–309, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Halari, R. Mehrotra, T. Sharma, V. Ng, and V. Kumari, “Cognitive impairment but preservation of sexual dimorphism in cognitive abilities in chronic schizophrenia,” Psychiatry Research, vol. 141, no. 2, pp. 129–139, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. R. I. Mesholam-Gately, A. J. Giuliano, K. P. Goff, S. V. Faraone, and L. J. Seidman, “Neurocognition in first-episode schizophrenia: a meta-analytic review,” Neuropsychology, vol. 23, no. 3, pp. 315–336, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Jiménez, A. Mancini-Marïe, and A. Mendrek, “The case for not combining men and women in neurocognitive studies for schizophrenia,” Schizophrenia Research, vol. 108, no. 1–3, pp. 293–294, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. J. A. Jiménez, A. Mancini-Marïe, N. Lakis, M. Rinaldi, and A. Mendrek, “Disturbed sexual dimorphism of brain activation during mental rotation in schizophrenia,” Schizophrenia Research, vol. 122, no. 1–3, pp. 53–62, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Gogos, M. Gavrilescu, S. Davison et al., “Greater superior than inferior parietal lobule activation with increasing rotation angle during mental rotation: an fMRI study,” Neuropsychologia, vol. 48, no. 2, pp. 529–535, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Hattemer, A. Plate, J. T. Heverhagen et al., “Determination of hemispheric dominance with mental rotation using functional transcranial Doppler sonography and FMRI,” Journal of Neuroimaging, vol. 21, no. 1, pp. 16–23, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. H. E. Schendan and C. E. Stern, “Mental rotation and object categorization share a common network of prefrontal and dorsal and ventral regions of posterior cortex,” NeuroImage, vol. 35, no. 3, pp. 1264–1277, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. T. Butler, J. Imperato-McGinley, H. Pan et al., “Sex differences in mental rotation: top-down versus bottom-up processing,” NeuroImage, vol. 32, no. 1, pp. 445–456, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Alonso-Solís, I. Corripio, P. de Castro-Manglano et al., “Altered default network resting state functional connectivity in patients with a first episode of psychosis,” Schizophrenia Research, vol. 139, no. 1–3, pp. 13–18, 2012. View at Google Scholar
  41. J. Bourque, N. Lakis, J. Champagne et al., “Clozapine and visuospatial processing in treatment-resistant schizophrenia,” Cognitive Neuropsychiatry, 2013. View at Publisher · View at Google Scholar
  42. L. Deserno, P. Sterzer, T. Wüstenberg, A. Heinz, and F. Schlagenhauf, “Reduced prefrontal-parietal effective connectivity and working memory deficits in schizophrenia,” Journal of Neuroscience, vol. 32, no. 1, pp. 12–20, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. L. B. N. Hinkley, S. Vinogradov, A. G. Guggisberg, M. Fisher, A. M. Findlay, and S. S. Nagarajan, “Clinical symptoms and alpha band resting-state functional connectivity imaging in patients with schizophrenia: implications for novel approaches to treatment,” Biological Psychiatry, vol. 70, no. 12, pp. 1134–1142, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. Q. Wang, C. Cheung, W. Deng et al., “Fronto-parietal white matter microstructural deficits are linked to performance IQ in a first-episode schizophrenia Han Chinese sample,” Psychological Medicine, pp. 1–10, 2012. View at Publisher · View at Google Scholar
  45. APA, Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association, Washington, DC, USA, 4th edition, 1994.
  46. R. L. Spitzer, J. B. W. Williams, M. Gibbon, and M. B. First, “The structured clinical interview for DSM-III-R (SCID): I: history, rationale, and description,” Archives of General Psychiatry, vol. 49, no. 8, pp. 624–629, 1992. View at Google Scholar · View at Scopus
  47. S. R. Kay, A. Fiszbein, and L. A. Opler, “The positive and negative syndrome scale (PANSS) for schizophrenia,” Schizophrenia Bulletin, vol. 13, no. 2, pp. 261–276, 1987. View at Google Scholar · View at Scopus
  48. S. W. Woods, “Chlorpromazine equivalent doses for the newer atypical antipsychotics,” Journal of Clinical Psychiatry, vol. 64, no. 6, pp. 663–667, 2003. View at Google Scholar · View at Scopus
  49. H. R. D. Canada, The National Occupational Classification 2001, HRaSD, Ottawa, Canada, 2001.
  50. R. N. Shepard and J. Metzler, “Mental rotation of three-dimensional objects,” Science, vol. 171, no. 3972, pp. 701–703, 1971. View at Google Scholar · View at Scopus
  51. N. Lakis, J. A. Jiménez, A. Mancini-Marïe, E. Stip, M. E. Lavoie, and A. Mendrek, “Neural correlates of emotional recognition memory in schizophrenia: effects of valence and arousal,” Psychiatry Research, vol. 194, no. 3, pp. 245–256, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. K. J. Friston, “Commentary and opinion: II. Statistical parametric mapping: ontology and current issues,” Journal of Cerebral Blood Flow and Metabolism, vol. 15, no. 3, pp. 361–370, 1995. View at Google Scholar · View at Scopus
  53. A. P. Holmes and K. J. Friston, “Generalisability, random effects & population inference,” NeuroImage, vol. 7, no. 4, p. S754, 1998. View at Google Scholar · View at Scopus
  54. N. Tzourio-Mazoyer, B. Landeau, D. Papathanassiou et al., “Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain,” NeuroImage, vol. 15, no. 1, pp. 273–289, 2002. View at Publisher · View at Google Scholar · View at Scopus
  55. M. C. Jockers-Scherübl, T. Wolf, N. Radzei et al., “Cannabis induces different cognitive changes in schizophrenic patients and in healthy controls,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 31, no. 5, pp. 1054–1063, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. J. Stirling, S. Lewis, R. Hopkins, and C. White, “Cannabis use prior to first onset psychosis predicts spared neurocognition at 10-year follow-up,” Schizophrenia Research, vol. 75, no. 1, pp. 135–137, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. K. Jordan, H.-J. Heinze, K. Lutz, M. Kanowski, and L. Jäncke, “Cortical activations during the mental rotation of different visual objects,” NeuroImage, vol. 13, no. 1, pp. 143–152, 2001. View at Publisher · View at Google Scholar · View at Scopus
  58. A. Sekiguchi, S. Yokoyama, S. Kasahara et al., “Neural bases of a specific strategy for visuospatial processing in rugby players,” Medicine and Science in Sports and Exercise, vol. 43, no. 10, pp. 1857–1862, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. C. Ecker, M. J. Brammer, A. S. David, and S. C. Williams, “Time-resolved fMRI of mental rotation revisited—dissociating visual perception from mental rotation in female subjects,” NeuroImage, vol. 32, no. 1, pp. 432–444, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. J. Vanrie, E. Béatse, J. Wagemans, S. Sunaert, and P. van Hecke, “Mental rotation versus invariant features in object perception from different viewpoints: an fMRI study,” Neuropsychologia, vol. 40, no. 7, pp. 917–930, 2002. View at Google Scholar · View at Scopus
  61. R. Seurinck, G. Vingerhoets, F. P. de Lange, and E. Achten, “Does egocentric mental rotation elicit sex differences?” NeuroImage, vol. 23, no. 4, pp. 1440–1449, 2004. View at Publisher · View at Google Scholar · View at Scopus
  62. G. Vingerhoets, F. P. de Lange, P. Vandemaele, K. Deblaere, and E. Achten, “Motor imagery in mental rotation: an fMRI study,” NeuroImage, vol. 17, no. 3, pp. 1623–1633, 2002. View at Publisher · View at Google Scholar · View at Scopus
  63. C. Lamm, C. Windischberger, E. Moser, and H. Bauer, “The functional role of dorso-lateral premotor cortex during mental rotation: an event-related fMRI study separating cognitive processing steps using a novel task paradigm,” NeuroImage, vol. 36, no. 4, pp. 1374–1386, 2007. View at Google Scholar
  64. M. S. Cohen, S. M. Kosslyn, H. C. Breiter et al., “Changes in cortical activity during mental rotation—a mapping study using functional MRI,” Brain, vol. 119, part 1, pp. 89–100, 1996. View at Publisher · View at Google Scholar · View at Scopus
  65. K. Podzebenko, G. F. Egan, and J. D. G. Watson, “Widespread dorsal stream activation during a parametric mental rotation task, revealed with functional magnetic resonance imaging,” NeuroImage, vol. 15, no. 3, pp. 547–558, 2002. View at Publisher · View at Google Scholar · View at Scopus
  66. C. Windischberger, C. Lamm, H. Bauer, and E. Moser, “Human motor cortex activity during mental rotation,” NeuroImage, vol. 20, no. 1, pp. 225–232, 2003. View at Publisher · View at Google Scholar · View at Scopus
  67. I. M. Harris, G. F. Egan, C. Sonkkila, H. J. Tochon-Danguy, G. Paxinos, and J. D. G. Watson, “Selective right parietal lobe activation during mental rotation. A parametric PET study,” Brain, vol. 123, part 1, pp. 65–73, 2000. View at Google Scholar · View at Scopus
  68. W. Byne, E. A. Hazlett, M. S. Buchsbaum, and E. Kemether, “The thalamus and schizophrenia: current status of research,” Acta Neuropathologica, vol. 117, no. 4, pp. 347–368, 2009. View at Publisher · View at Google Scholar · View at Scopus
  69. W. J. Cronenwett and J. Csernansky, “Thalamic pathology in schizophrenia,” Current Topics in Behavioral Neurosciences, vol. 4, pp. 509–528, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. A. T. Sack, “Parietal cortex and spatial cognition,” Behavioural Brain Research, vol. 202, no. 2, pp. 153–161, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. D. Piomelli, “The molecular logic of endocannabinoid signalling,” Nature Reviews Neuroscience, vol. 4, no. 11, pp. 873–884, 2003. View at Publisher · View at Google Scholar · View at Scopus
  72. J. Desfossés, E. Stip, L. A. Bentaleb, and S. Potvin, “Endocannabinoids and schizophrenia,” Pharmaceuticals, vol. 3, no. 10, pp. 3101–3126, 2010. View at Publisher · View at Google Scholar · View at Scopus
  73. A. J. Sánchez and A. García-Merino, “Neuroprotective agents: cannabinoids,” Clinical Immunology, vol. 142, no. 1, pp. 57–67, 2012. View at Publisher · View at Google Scholar · View at Scopus
  74. N. Solowij and R. Battisti, “The chronic effects of cannabis on memory in humans: a review,” Current Drug Abuse Reviews, vol. 1, no. 1, pp. 81–98, 2008. View at Google Scholar · View at Scopus
  75. R. Martín-Santos, A. B. Fagundo, J. A. Crippa et al., “Neuroimaging in cannabis use: a systematic review of the literature,” Psychological Medicine, vol. 40, no. 3, pp. 383–398, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. M. G. Bossong, G. Jager, H. H. van Hell et al., “Effects of Δ9-tetrahydrocannabinol administration on human encoding and recall memory function: a pharmacological fMRI study,” Journal of Cognitive Neuroscience, vol. 24, no. 3, pp. 588–599, 2012. View at Publisher · View at Google Scholar · View at Scopus
  77. S. Bhattacharyya, P. Fusar-Poli, S. Borgwardt et al., “Modulation of mediotemporal and ventrostriatal function in humans by A9-tetrahydrocannabinol a neural basis for the effects of cannabis sativa on learning and psychosis,” Archives of General Psychiatry, vol. 66, no. 4, pp. 442–451, 2009. View at Publisher · View at Google Scholar · View at Scopus
  78. L. Chang, R. Yakupov, C. Cloak, and T. Ernst, “Marijuana use is associated with a reorganized visual-attention network and cerebellar hypoactivation,” Brain, vol. 129, part 5, pp. 1096–1112, 2006. View at Publisher · View at Google Scholar · View at Scopus
  79. G. Kanayama, J. Rogowska, H. G. Pope, S. A. Gruber, and D. A. Yurgelun-Todd, “Spatial working memory in heavy cannabis users: a functional magnetic resonance imaging study,” Psychopharmacology, vol. 176, no. 3-4, pp. 239–247, 2004. View at Publisher · View at Google Scholar · View at Scopus
  80. D. C. D'Souza, W. M. Abi-Saab, S. Madonick et al., “Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction,” Biological Psychiatry, vol. 57, no. 6, pp. 594–608, 2005. View at Publisher · View at Google Scholar · View at Scopus
  81. S. S. Bangalore, K. M. R. Prasad, D. M. Montrose, D. D. Goradia, V. A. Diwadkar, and M. S. Keshavan, “Cannabis use and brain structural alterations in first episode schizophrenia—a region of interest, voxel based morphometric study,” Schizophrenia Research, vol. 99, no. 1–3, pp. 1–6, 2008. View at Publisher · View at Google Scholar · View at Scopus
  82. M. Rais, W. Cahn, N. van Haren et al., “Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients,” American Journal of Psychiatry, vol. 165, no. 4, pp. 490–496, 2008. View at Publisher · View at Google Scholar · View at Scopus
  83. W. Cahn, H. E. Hulshoff Pol, E. Caspers, N. E. M. van Haren, H. G. Schnack, and R. S. Kahn, “Cannabis and brain morphology in recent-onset schizophrenia,” Schizophrenia Research, vol. 67, no. 2-3, pp. 305–307, 2004. View at Publisher · View at Google Scholar · View at Scopus
  84. M. Cohen, P. E. Rasser, G. Peck et al., “Cerebellar grey-matter deficits, cannabis use and first-episode schizophrenia in adolescents and young adults,” International Journal of Neuropsychopharmacology, vol. 15, no. 3, pp. 297–307, 2012. View at Publisher · View at Google Scholar · View at Scopus
  85. N. Dekker, N. Schmitz, B. D. Peters, T. A. van Amelsvoort, D. H. Linszen, and L. de Haan, “Cannabis use and callosal white matter structure and integrity in recent-onset schizophrenia,” Psychiatry Research, vol. 181, no. 1, pp. 51–56, 2010. View at Publisher · View at Google Scholar · View at Scopus
  86. C. C. Joyal, P. Hallé, D. Lapierre, and S. Hodgins, “Drug abuse and/or dependence and better neuropsychological performance in patients with schizophrenia,” Schizophrenia Research, vol. 63, no. 3, pp. 297–299, 2003. View at Publisher · View at Google Scholar · View at Scopus
  87. K. T. Mueser, P. R. Yarnold, S. D. Rosenberg, C. Swett Jr., K. M. Miles, and D. Hill, “Substance use disorder in hospitalized severely mentally ill psychiatric patients: prevalence, correlates, and subgroups,” Schizophrenia Bulletin, vol. 26, no. 1, pp. 179–192, 2000. View at Google Scholar · View at Scopus
  88. A. Batalla, S. Bhattacharyya, M. Yücel et al., “Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings,” PLoS One, vol. 8, no. 2, Article ID e55821, 2013. View at Google Scholar